Document Details

ElegantFeynman2613

Uploaded by ElegantFeynman2613

Creighton University

Dr. Janee Gelineau-vanWaes

Tags

antifungal drugs pharmacology medicine healthcare

Summary

This presentation details antifungal medications, their mechanisms of action, toxicity, and administration. It covers topics like systemic and superficial mycoses and includes information on different drugs like amphotericin B and azoles.

Full Transcript

Antifungal Medications NUR 331 Powerpoint created by: Dr. Janee Gelineau-vanWaes, Pharmacology Department, Creighton University School of Medicine FUNGAL DISEASES Systemic Mycoses -involve various internal organs; difficult to treat;...

Antifungal Medications NUR 331 Powerpoint created by: Dr. Janee Gelineau-vanWaes, Pharmacology Department, Creighton University School of Medicine FUNGAL DISEASES Systemic Mycoses -involve various internal organs; difficult to treat; toxic medications Superficial Mycoses (yeast) -involve skin, nails, or mucous membrane SYSTEMIC FUNGAL INFECTIONS (1) OPPORTUNISTIC MYCOSES - Occur primarily in debilitated and/or immunocompromised patients (AIDS, leukemia, lymphoma) – Candida, Aspergillus, Cryptococcus, Phycomycetes (2) ENDEMIC MYCOSES (Non-opportunistic) - Caused by various pathogens distributed unevenly around the world, can occur in any host - Blastomycosis - Histoplasmosis - Coccidiomycosis – Valley Fever - Sporotrichosis ENDEMIC MYCOSES 2 Major Classes of Antifungal Drugs Polyene antibiotics (Amphotericin B, Nystatin) Azoles (Fluconazole, Itraconazole, Ketoconazole, Clotrimazole) Two other classes exist - Echinocandins and Pyrimidine analogs POLYENE ANTIFUNGAL AGENTS AMPHOTERICIN B - used to treat deep systemic mycoses - before Amphotericin B, most systemic infections were fatal NYSTATIN - useful in treatment superficial mycoses of candidiasis (skin, mouth, esophagus, vagina) POLYENE ANTIFUNGAL AGENTS MECHANISM OF ACTION → binds to ergosterol, a component of the fungal cell membrane → binding forms channels in the cell membrane, increasing its permeability → cells leak intracellular cations (Na+, K+, and H+ ions) *Resistance to polyenes is associated with replacement of ergosterol by other sterols in the fungal plasma membrane CAUTION with Amphotericin B -Broad-spectrum antifungal agent; drug of choice for systemic mycoses -Highly toxic; fungistatic or fungicidal depending on pH, concentration, and fungus -Effective against some protozoa (Leishmania) -Infusion reaction and renal damage occur in ALL patients to varying degrees -Extent of kidney damage related to total dose (minimized by infusing additional normal saline) -Be careful with other nephrotoxic drugs! AMPHOTERICIN B Administration -absorbed poorly from GI tract (oral therapy not effective) -administer by slow IV infusion over 2-6 hours every day or every other day for several months (3-4 months) -infusion reactions (fever, chills, rigors, nausea, headache) -symptoms begin 1-3 hours after start of infusion; less intense with lipid-based infusion; can give acetaminophen, diphenhydramine -hypokalemia from kidney damage; may need supplements -can cause bone marrow suppression Azoles -broad spectrum synthetic compounds for treating systemic mycoses -less toxic than Amphotericin B -can be given orally -disadvantage: Inhibits P450 drug-metabolizing enzymes and can increase levels of other drugs Itraconazole (Sporanox) Newer broad-spectrum azoles valuable Fluconazole (Diflucan) for severe fungal infections in Ketoconazole (Nizoral) immunocompromised patients Mechanism of Action -inhibits enzyme involved in the synthesis of fungal ergosterol; inhibits cytochrome P450 enzymes increasing levels of other drugs Itraconazole (Sporanox)  -broader spectrum than most azoles  -well absorbed from GI when given with meals  -highly bound to plasma proteins (>99%)  -long half-life, ~20 hours after single dose  -mostly metabolized in the liver  -adverse reactions include cardiosuppression, hepatotoxicity, hypokalemia, hypertension FLUCONAZOLE – Therapeutic Uses (Diflucan) -well absorbed from the GI tract & distributed throughout body, including CNS -effective in immunocompromised patients -teatment of cryptococcal meningitis; blastomycosis, histoplasmosis -long half-life (20-50 hrs adults; 17 hrs children) -excreted largely unchanged in kidney -treatment of mucosal (oropharyngeal/esophageal) candidiasis -weekly prophylaxis against mucosal candidiasis in HIV/AIDS FLUCONAZOLE – Adverse Effects - GI disturbances - nausea, vomiting, gastric pain - Headaches - Rashes - Seizures - Anaphylaxis - Dermatitis *high doses during first trimester of pregnancy can cause birth defects KETOCONAZOLE (Nizoral) - 1st oral antifungal approved for chronic systemic mycoses - well absorbed from GI if stomach content is acidic - generally well tolerated - antacids and H2 antihistamines markedly ↓ absorption KETOCONAZOLE Toxicity - < toxic alternative to Amphotericin - Severe hepatotoxicity in approx. 0.01% of individuals - Markedly inhibits synthesis of testosterone and estradiol → gynecomastia → menstrual irregularities → alterations in adrenal steroid synthesis Common superficial mycoses (fungal infections) Tinea pedis – ringworm of the foot “athlete’s foot” Tinea corporis – ringworm of the body Tinea cruris – ringworm of the groin “jock itch” Tinea capitis – ringworm of the scalp Vulvovaginal candidiasis Oral Candidiasis (thrush) Onychomycosis (fungal infection of nails) Treated with topical and/or oral drugs TOLNAFTATE – superficial mycoses -thiocarbamate commonly used as topical antifungal agent -superficial skin and nail infections (tinea pedis, tinea cruris, etc.) -generally ineffective against yeast (ie. Candida) -adverse effects involve allergic contact dermatitis, possibly teratogenic NYSTATIN (Polyene) -not much absorption from skin, mucous membranes, or GI -used primarily to treat candidal infections of mucosa, skin, intestinal tract and vagina -topical Nystatin remains drug of choice for treatment of candidal infections of the oral cavity - Oral moniliasis - Thrush - Denture stomatitis CLOTRIMAZOLE -Used for various mucosal and cutaneous infections -Spectrum and MOA similar to other azoles -Restricted to topical use (1% cream or lotion) -Preparation available specifically for intraoral use MICONAZOLE - 1st azole approved for topical and parenteral use - no longer used systemically and specific formulation for intraoral use unavailable - 2% miconazole nitrate cream used for cutaneous and vaginal Candida albicans infections - may cause burning, redness, itching (Micatin, Monistat) RINGWORM Athlete’s Foot

Use Quizgecko on...
Browser
Browser